Gueiros 2019.
Methods | Single‐centre parallel RCT (open label) |
Participants | PD patients |
Interventions | Spironolactone |
Outcomes | Relative and absolute progression of the coronary calcium score; hyperkalaemia; adverse effects (hypotension, hyperpotassaemia, gynaecomastia); mineral metabolism at 12 months; change in inflammation markers at 12 months; causes of study discontinuation |
Notes | Protocol registration only; recruitment completed, current status is unknown |